SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for INBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
March 31, 2026 2.459M
December 31, 2025 2.337M
September 30, 2025 2.660M
June 30, 2025 2.718M
March 31, 2025 2.408M
December 31, 2024 1.809M
September 30, 2024 1.949M
June 30, 2024 2.671M
March 31, 2024 2.426M
December 31, 2023 1.705M
September 30, 2023 2.457M
June 30, 2023 2.432M
March 31, 2023 1.899M
December 31, 2022 2.245M
September 30, 2022 1.450M
June 30, 2022 1.462M
March 31, 2022 1.122M
December 31, 2021 1.003M
September 30, 2021 1.332M
June 30, 2021 1.153M
Date Value
March 31, 2021 1.013M
December 31, 2020 0.6714M
September 30, 2020 0.521M
June 30, 2020 0.4509M
March 31, 2020 0.0538M
December 31, 2019 0.972M
September 30, 2019 0.3043M
June 30, 2019 0.2549M
March 31, 2019 1.018M
December 31, 2018 0.4857M
September 30, 2018 0.00
June 30, 2018 0.7676M
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Sanara MedTech, Inc. 21.88M
Anteris Technologies Global Corp. 6.93M
20/20 Biolabs, Inc. 1.353M
FONAR Corp. 8.373M
Quest Diagnostics, Inc. 504.00M